Singapore markets open in 4 hours 17 minutes

Vicarious Surgical Inc. (RBOT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.8300+0.0100 (+0.35%)
As of 03:42PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 402.60M
Enterprise value 292.49M
Trailing P/E 7.05
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.17
Enterprise value/revenue N/A
Enterprise value/EBITDA 7.49

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 3-73.84%
S&P500 52-week change 3-14.68%
52-week high 312.1000
52-week low 32.6900
50-day moving average 33.4644
200-day moving average 34.0712

Share statistics

Avg vol (3-month) 3247k
Avg vol (10-day) 3623.16k
Shares outstanding 5102.72M
Implied shares outstanding 6N/A
Float 847.53M
% held by insiders 137.56%
% held by institutions 138.93%
Shares short (14 Nov 2022) 43.42M
Short ratio (14 Nov 2022) 417.96
Short % of float (14 Nov 2022) 47.33%
Short % of shares outstanding (14 Nov 2022) 42.79%
Shares short (prior month 13 Oct 2022) 43.19M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-28.08%
Return on equity (ttm)45.59%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -76.45M
Net income avi to common (ttm)38.12M
Diluted EPS (ttm)0.3900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)126.8M
Total cash per share (mrq)1.04
Total debt (mrq)16.69M
Total debt/equity (mrq)15.32
Current ratio (mrq)11.25
Book value per share (mrq)0.89

Cash flow statement

Operating cash flow (ttm)-52.55M
Levered free cash flow (ttm)-31.87M